Orexigen Drops as Diet Pill Gets Put on Hold

Diet pill maker Orexigen Therapeutics' (OREX) says it's suspending development of weight–loss drug Contrave in the US after failing to reach agreement with government officials on steps for approval of the product. Shares of Orexigen are dropping in …
See all stories on this topic »